Patents by Inventor Nicolas Noiret

Nicolas Noiret has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Composition for therapeutic use, including an organic lipid phase and a rare-earth radioisotope complex
    Patent number: 9579409
    Abstract: The invention relates to a therapeutic composition including a complex having the following formula (1), including a rare-earth radioisotope in ionic form, said complex being solubilized in an organic lipophilic phase: [M(L)3] in which: M denotes the rare-earth radioisotope in ionic form, and L denotes a tropolone ligand or a ligand derived from tropolone.
    Type: Grant
    Filed: July 17, 2013
    Date of Patent: February 28, 2017
    Assignees: CENTRE EUGENE MARQUIS, ECOLE NATIONALE SUPERIEURE DE CHIME, UNIVERSITE DE RENNES I
    Inventors: Nicolas Lepareur, Etienne Garin, Nicolas Noiret, Valerie Ardisson
  • COMPOSITION FOR THERAPEUTIC USE, INCLUDING AN ORGANIC LIPID PHASE AND A RARE-EARTH RADIOISOTOPE COMPLEX
    Publication number: 20150202334
    Abstract: The invention relates to a therapeutic composition including a complex having the following formula (1), including a rare-earth radioisotope in ionic form, said complex being solubilized in an organic lipophilic phase: [M(L)3] in which: M denotes the rare-earth radioisotope in ionic form, and L denotes a tropolone ligand or a ligand derived from tropolone.
    Type: Application
    Filed: July 17, 2013
    Publication date: July 23, 2015
    Inventors: Nicolas Lepareur, Etienne Garin, Nicolas Noiret, Valerie Ardisson
  • Plasticizers for aqueous suspensions of mineral particles and hydraulic binder pastes
    Patent number: 9012589
    Abstract: The invention relates to a compound of following formula (I): the preparation method thereof and the use of same.
    Type: Grant
    Filed: March 31, 2010
    Date of Patent: April 21, 2015
    Assignee: Chryso
    Inventors: Philippe Maitrasse, Bruno Pellerin, Frederic Leising, Loic Lemiegre, Nicolas Noiret, Nathanael Olivi
  • Technetium or rhenium complexes, radiopharmaceutical products comprising them
    Publication number: 20050008568
    Abstract: The invention relates to a technetium or rhenium complex of formula (I): [M (R1CS3)2L]??(I) in which M is Tc or Re, R1 represents an alkyl, cycloalkyl, aralkyl or aryl group which is unsubstituted or substituted by one or more substituents chosen from halogen atoms, the hydroxyl group, alkyl groups and alkoxy groups, and L is a dithiolate ligand, with the exception of the ligand of formula R2CS2 in which R2 is identical to R1. The dithiolate ligand is preferably a dithiocarbamate. The invention also relates to a radiopharmaceutical product comprising a complex of formula (I) with M representing 99Tc, 186Re or 188Re.
    Type: Application
    Filed: November 5, 2002
    Publication date: January 13, 2005
    Inventors: Franck Mevellec, Roberto Pasqualini, Henri Patin, Alain Roucoux, Nicolas Noiret
  • Radiopharmaceutical products suitable for the selective labeling of lymphocytes, and their preparation
    Patent number: 6469146
    Abstract: The invention concerns radiopharmaceutical products suitable for the selective labeling of lymphomas containing a metal complex with the formula: [M(R1CS2)(R1CS3)2] in which M is chosen from among 99mTc, 186Re and 188Re, and R1 represents an alkyl, cycloalkyl, aralkyl or aryl group, optionally substituted, obtained by reaction of a pertechnetate or a perrhenate with a reducing agent such as SnCl2ZP2O in the presence of a dithiocarboxylate having the formula: (R1CS2)−Z2+.
    Type: Grant
    Filed: May 31, 2000
    Date of Patent: October 22, 2002
    Assignee: Cis Bio International
    Inventors: Roberto Pasqualini, Emmanuel Bellande, Franck Mevellec, Alain Roucoux, Nicolas Noiret, Henri Patin